Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Colorectal Neoplasms

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 35 articles:
HTML format



Single Articles


    March 2023
  1. CALLISON K, Pesko MF, Phillips S, Sosa JA, et al
    Cancer Screening after the Adoption of Paid-Sick-Leave Mandates.
    N Engl J Med. 2023;388:824-832.
    PubMed     Abstract available


    January 2023
  2. DOMINITZ JA, Robertson DJ
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
    N Engl J Med. 2023;388:379.
    PubMed    


  3. BRETTHAUER M, Loberg M, Kaminski MF
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
    N Engl J Med. 2023;388:378-379.
    PubMed    


  4. CAPPELL MS, Tobi M, Yang YX
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:378.
    PubMed    


  5. HOFFMEISTER M, Cardoso R, Brenner H
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377-378.
    PubMed    


  6. WINAWER SJ
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377.
    PubMed    


  7. DECK W
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376-377.
    PubMed    


  8. HANLEY JA
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376.
    PubMed    


    December 2022
  9. YAEGER R, Weiss J, Pelster MS, Spira AI, et al
    Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
    N Engl J Med. 2022 Dec 21. doi: 10.1056/NEJMoa2212419.
    PubMed     Abstract available


    November 2022
  10. PAPKE DJ JR, Yurgelun MB, Noffsinger AE, Turner KO, et al
    Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas.
    N Engl J Med. 2022;387:1714-1716.
    PubMed    


    October 2022
  11. DOMINITZ JA, Robertson DJ
    Understanding the Results of a Randomized Trial of Screening Colonoscopy.
    N Engl J Med. 2022;387:1609-1611.
    PubMed    


  12. BRETTHAUER M, Loberg M, Wieszczy P, Kalager M, et al
    Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.
    N Engl J Med. 2022 Oct 9. doi: 10.1056/NEJMoa2208375.
    PubMed     Abstract available


    September 2022
  13. CERCEK A, Diaz LA Jr
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer. Reply.
    N Engl J Med. 2022;387:855-856.
    PubMed    


  14. GANGULY S, Gogia A
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:855.
    PubMed    


  15. COPUR MS, Tun SM, Duckert R
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:854-855.
    PubMed    


    August 2022
  16. TIE J, Lo SN, Gibbs P
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer. Reply.
    N Engl J Med. 2022;387:760.
    PubMed    


  17. OTSUKA M
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759-760.
    PubMed    


  18. HINDIE E
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759.
    PubMed    


  19. PALEFSKY JM, Lee JY
    Prevention of Anal Cancer. Reply.
    N Engl J Med. 2022;387:666-667.
    PubMed    


  20. REVOLLO B, Videla S, Llibre JM
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:666.
    PubMed    


  21. KREUTER A, Wieland U
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665-666.
    PubMed    


  22. GOFFREDO P, Klemen ND, Hassan I
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665.
    PubMed    


    July 2022
  23. SINICROPE FA
    The Increasing Incidence of Early-Onset Colorectal Cancer. Reply.
    N Engl J Med. 2022;387:93-94.
    PubMed    


  24. GOLDSTEIN MR, Mascitelli L
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:93.
    PubMed    


  25. WOLOSHIN S, Kramer BS
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:91-93.
    PubMed    


    June 2022
  26. SANOFF HK
    Improving Treatment Approaches for Rectal Cancer.
    N Engl J Med. 2022;386:2425-2426.
    PubMed    


  27. CERCEK A, Lumish M, Sinopoli J, Weiss J, et al
    PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
    N Engl J Med. 2022;386:2363-2376.
    PubMed     Abstract available


  28. PALEFSKY JM, Lee JY, Jay N, Goldstone SE, et al
    Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
    N Engl J Med. 2022;386:2273-2282.
    PubMed     Abstract available


  29. BASGOZ N, Brown CM, Smole SC, Madoff LC, et al
    Case 24-2022: A 31-Year-Old Man with Perianal and Penile Ulcers, Rectal Pain, and Rash.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMcpc2201244.
    PubMed    


  30. TIE J, Cohen JD, Lahouel K, Lo SN, et al
    Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMoa2200075.
    PubMed     Abstract available


  31. MONTAGUT C, Vidal J
    Liquid Biopsy for Precision Adjuvant Chemotherapy in Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMe2204625.
    PubMed    


    April 2022
  32. SINICROPE FA
    Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;386:1547-1558.
    PubMed    


    February 2022
  33. DOUBENI CA, Corley DA, Zhao W, Lau Y, et al
    Association between Improved Colorectal Screening and Racial Disparities.
    N Engl J Med. 2022;386:796-798.
    PubMed    


  34. MIN A, Ditkofsky N
    Page Kidneys.
    N Engl J Med. 2022;386:673.
    PubMed    


    January 2022
  35. HORN DM, Haas JS
    Expanded Lung and Colorectal Cancer Screening - Ensuring Equity and Safety under New Guidelines.
    N Engl J Med. 2022 Jan 8. doi: 10.1056/NEJMp2113332.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: